Alicon Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Palghar, Maharashtra, India, established in 1995.
1995 Palghar, Maharashtra, India Active
Last Updated:
Access Report
About Alicon Pharmaceutical Private Limited

Alicon Pharmaceutical Private Limited, a active private limited company, was established on 07 March 1995 in Palghar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U99999MH1995PTC086137. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.50 M.

It upholds a compliant status. Employing 56 professional, Its leadership includes Nitinbhai Popatbhai Savani (Director), Priyank Batukbhai Savani (Director), Mayuri Priyankkumar Savani (Director). Past directors included Nitinbhai Popatbhai Savani, Priyank Batukbhai Savani, Mayuri Priyankkumar Savani. It holds ₹29.50 Cr open charges and ₹7.84 Cr settled loans. Its latest AGM occurred on 12 November 2024, with the balance sheet filed on 31 March 2024. It is based at 147/6, Nagasai Apartment, Shirgaon Road, Chandansar Road, Virar East, Virar,, Palghar, Maharashtra, 401305.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U99999MH1995PTC086137

  • Registration Number

    086137

  • Incorporation Date

    07 March 1995

  • Authorized Capital

    ₹7.50 M

  • Paid-Up Capital

    ₹7.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.50 M
  • Paid Up Capital ₹ 7.50 M
  • Company Age 30 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 29.50 Cr
  • Satisfied Charges ₹ 7.84 Cr
  • Revenue Growth **** 28.37%
  • Profit Growth **** 102.51%
  • Ebitda **** 68.86%
  • Net Worth 27.14%
  • Total Assets -8.47%
Company report

Alicon Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Alicon Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Alicon Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Nitinbhai Popatbhai Savani Director 22 Oct 2018 Current
Priyank Batukbhai Savani Director 16 Feb 2018 Current
Mayuri Priyankkumar Savani Director 21 Mar 2022 Current
Ashish Dayashanker Singh Director 01 Feb 2020 Current
Anup Omprakash Tapadiya Director 22 Oct 2018 Current
Chandan Rajgopal Soni Director 16 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 22 Oct 2018 Past
Pramod Abcsdd Director 07 Feb 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Alicon Pharmaceutical.

Alicon Pharmaceutical Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 28.37% increase. The company also saw a substantial improvement in profitability, with a 102.51% increase in profit. The company's net worth Soared by an impressive increase of 27.14%.

Alicon Pharmaceutical revenue growth over time
Alicon Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 28.37%
*******
*******
*******
*******
Revenue from Operations
*******
 28.73%
*******
*******
*******
*******
Total Assets
*******
 -8.47%
*******
*******
*******
*******
Profit or Loss
*******
 102.51%
*******
*******
*******
*******
Net Worth
*******
 27.14%
*******
*******
*******
*******
EBITDA
*******
 68.86%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Alicon Pharmaceutical?

Unlock access to Alicon Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹295,000,000.00

Satisfied Charges

₹78,430,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 20.00 Cr
  • Others : 9.50 Cr
Latest Charge Details
Date Lender Amount Status
26 Mar 2024 Bank Of India ₹20.00 Cr Open
11 Sep 2019 Others ₹5.00 M Open
20 Dec 2018 Others ₹5.00 Cr Open
20 Dec 2018 Others ₹4.00 Cr Open
16 Jul 2014 Union Bank Of India ₹8.25 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Alicon Pharmaceutical?

Alicon Pharmaceutical has a workforce of 56 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Alicon Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alicon Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Alicon Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    The activity Alicon Pharmaceutical Private Limited last Annual general meeting of members was held on 12 Nov 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Alicon Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Charges

    The activity A charge with Bank Of India amounted to Rs. 200.00 M with Charge ID 100911266 was registered on 26 Mar 2024. was completed.

  • Director Appointment

    Mayuri Priyankkumar Savani was appointed as a Director was appointed as a Director on 21 Mar 2022 & has been associated with this company since 3 years 11 months . was recorded as a recent event.

  • Director Appointment

    Ashish Dayashanker Singh was appointed as a Director was appointed as a Director on 01 Feb 2020 & has been associated with this company since 6 years 29 days . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 5.00 M with Charge ID 100296231 was registered on 11 Sep 2019. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Alicon Pharmaceutical Private Limited?

The CIN of Alicon Pharmaceutical Private Limited is U99999MH1995PTC086137.

Where is Alicon Pharmaceutical Private Limited headquartered?

Alicon Pharmaceutical Private Limited is headquartered at 147/6, Nagasai Apartment, Shirgaon Road, Chandansar Road, Virar East, Virar,, Palghar, Maharashtra, 401305.

When was Alicon Pharmaceutical Private Limited incorporated?

Alicon Pharmaceutical Private Limited was incorporated on 07 March 1995.

Who are the current directors of Alicon Pharmaceutical Private Limited?

The current directors of Alicon Pharmaceutical Private Limited are

What is the primary industry of Alicon Pharmaceutical Private Limited?

The primary industry of Alicon Pharmaceutical Private Limited is Manufacturing.

Is Alicon Pharmaceutical Private Limited a listed company?

Alicon Pharmaceutical Private Limited is unlisted.

What is the capital structure of Alicon Pharmaceutical Private Limited?

The authorized capital of Alicon Pharmaceutical Private Limited is ₹7.50 M, and the paid-up capital is ₹7.50 M.

What is the compliance status of Alicon Pharmaceutical Private Limited?

The compliance status of Alicon Pharmaceutical Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available